Tekes K, Karvaly G, Nurulain S, Kuca K, Musilek K, Adeghate E, Jung YS, Kalasz H (2019)
Pharmacokinetics of K117 and K127, two novel antidote candidates to treat Tabun poisoning
Chemico-Biological Interactions 310: 108737

Kassa J, Karasova JZ, Musilek K, Kuca K, Jung AY (2009)
A comparison of the neuroprotective efficacy of newly developed oximes (K117, K127) and currently available oxime (obidoxime) in tabun-poisoned rats
Toxicol Mech Methods 19: 232

Kuca K, Cabal J, Jung YS, Musilek K, Soukup O, Jun D, Pohanka M, Musilova L, Karasova J, Novotny L, Hrabinova M (2009)
Reactivation of human brain homogenate cholinesterases inhibited by Tabun using newly developed oximes K117 and K127
Basic Clin Pharmacol Toxicol 105: 207

Kassa J, Karasova J, Musilek K, Kuca K, Jung YS (2008)
A comparison of the therapeutic and reactivating efficacy of newly developed oximes (K117, K127) and currently available oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice
Drug & Chemical Toxicology 31: 371

Kim TH, Kuca K, Jun D, Jung YS (2005)
Design and synthesis of new bis-pyridinium oxime reactivators for acetylcholinesterase inhibited by organophosphorous nerve agents
Bioorganic & Medicinal Chemistry Lett 15: 2914